Contributors

Alan C. Aisenberg, MD, PhD, Professor, Department of Medicine, Harvard Medical School; Physician, Department of Hema-tology/Oncology, Massachusetts General Hospital, Boston, Massachusetts

Elias J. Anaissie, MD, Professor of Medicine, Arkansas Cancer Research Center, University of Arkansas for Medical Sciences, Little Rock, Arkansas

Claudio Anasetti, MD, Professor of Medicine, Division of Clinical Research, Fred Hutchinson Cancer Research Center, Department of Medicine, Division of Oncology, University of Washington, Seattle, Washington

Kenneth C.Anderson, MD, Professor of Medicine, Department of Adult Oncology, Dana-Farber Cancer Institute; Harvard Medical School, Boston, Massachusetts

Robert J. Arceci, MD, PhD, Director of Pediatric Oncology, King Fahd Professor of Pediatric Oncology, Johns Hopkins Oncology Center, Johns Hopkins University School of Medicine, Baltimore, Maryland

James O. Armitage, MD, Professor and Chairman, Department of Internal Medicine, University of Nebraska College of Medicine, Omaha, Nebraska

Monica Balzarotti, MD, Associate Director, Department of Medical Oncology and Hematology, Instituto Clinico Humanitas, Rozzano (Milano), Italy

Dalsu Baris, MD, PhD, Occupational Epidemiology Branch, National Cancer Institute, Bethesda, Maryland

Anthony Bench, PhD, Department of Haematology, University of Cambridge, Wellcome Trust Centre for Molecular Mechanisms in Disease, Cambridge Institute for Medical Research, Cambridge, England

John M. Bennett, MD, Professor, Department of Medicine, Pathology, and Laboratory Medicine, University of Rochester

School of Medicine and Dentistry; Attending Physician, Department of Medicine, Medical Oncology Unit, Strong Memorial Hospital, Rochester, New York

Daniel E. Bergsagel, CM, MD, D.Phil, Professor of Medicine, University of Toronto; Consultant Physician, Ontario Cancer Institute/Princess Margaret Hospital, Toronto, Ontario, Canada

P. Leif Bergsagel, MD, Associate Professor of Medicine, Division of Hematology-Oncology, New York Presbyterian Hospital/Cornell University, New York, New York

Philip J. Bierman, MD, Associate Professor, Section of Oncology and Hematology, Department of Internal Medicine, University of Nebraska College of Medicine, Omaha, Nebraska

Clara D. Bloomfield, MD, William G. Pace III Professor of Cancer Research; Director, The Ohio State University Comprehensive Cancer Center; Deputy Director, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, Ohio

Linda M. Brown, MPH, DrPH, Chief Health Services Officer; Assistant Chief, Biostatistics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland

Ray Cartwright, PhD, Leukaemia Research Fund Centre for Clinical Epidemiology at the University of Leeds, Institute of Epidemiology, Leeds, United Kingdom

Januario E. Castro, MD, Hematology/Oncology Division, University of California San Diego, San Diego, California

Dharminder Chauhan, PhD, Department of Adult Oncology, Dana-Farber Cancer Institute; Harvard Medical School, Boston, Massachusetts

David Choi, MD, PhD, Resident, Department of Neurology, Beth Israel, New England Deaconess Medical Center, Boston, Massachusetts

Richard J. Creger, PharmD, Comprehensive Cancer Center of the University Hospitals of Cleveland, Case Western Reserve University, Cleveland, Ohio

H. Joachim Deeg, MD, Professor, Department of Medicine, University of Washington School of Medicine; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington

Thomas G. DeLoughery, MD, Assistant Professor, Departments of Medicine and Pathology, Oregon Health Sciences University School of Medicine, Portland, Oregon

Susan S. Devesa, PhD, Chief, Descriptive Studies Section, Biostatistics Branch, Division of Cancer Etiology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland

Gordon Dewald, PhD, Professor of Laboratory Medicine and Medical Genetics, Mayo Clinic, Rochester, Minnesota

Maria Cecilia Dignani, MD, University of Arkansas for Medical Sciences, Little Rock, Arkansas

Meletios A. Dimopoulos, MD, Associate Professor of Medical Oncology, University of Athens School of Medicine, Athens, Greece

Angela Dispenzieri, MD, Assistant Professor of Medicine, Mayo Medical School; Consultant, Division of Hematology, Mayo Clinic, Rochester, Minnesota

Barbara K. Dunn, PhD, MD, Medical Officer, Division of Cancer Prevention, National Cancer Institute, Frederick, Maryland

Janice P. Dutcher, MD, Associate Director for Clinical Affairs, Our Lady of Mercy Cancer Center; Professor of Medicine, New York Medical College, Bronx, New York

Stefan Faderl, MD, Assistant Professor, Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, Texas

Rafael Fonseca, MD, Associate Professor of Medicine, Department of Internal Medicine, Division of Hematology, Mayo Clinic, Rochester, Minnesota

Emil J. Freireich, MD, DSc (Hon.), Special Medical Education Programs, The University of Texas M.D. Anderson Cancer Center, Houston, Texas

Robert E. Gallagher, MD, Professor, Departments of Medicine and Oncology, Albert Einstein College of Medicine of Yeshiva University; Attending Physician, Department of Oncology, Montefiore Medical Center, Bronx, New York

Morie A. Gertz, MD, Consultant, Division of Hematology and Internal Medicine, Mayo Clinic and Mayo Foundation; Professor of Medicine, Mayo Medical School, Rochester, Minnesota

John Gibson, MB, BS, FRACP, FRCPA, Associate Professor, Department of Medicine, University of Sidney; Senior Haema-tologist, Institute of Haematology, Royal Prince Alfred Hospital, Sydney, Australia

Nicola Gökbuget, MD, Department of Medicine (Haematology and Oncology) of the Johann Wolfgang-Goethe-University Frankfurt/Main, Germany

John M. Goldman, DM, Professor, Department of Haematol-ogy, Imperial College London, Hammersmith Hospital, London, England

Myrtle Y. Gordon, PhD, DSc, Professor, Department of Haema-tology, Imperial College London, Hammersmith Hospital, London, England

N. Claude Gorin, MD, Professor of Hematology, Service des Maladies du Sang, Unite de Therapie Cellulaire, Hôpital Saint Antoine, Paris, France

Anthony R. Green, PhD, Department of Haematology, University of Cambridge, Wellcome Trust Centre for Molecular Mechanisms of Disease, Cambridge Institute for Medical Research, Cambridge, England

Philip R. Greipp, MD, Professor, Departments of Medicine and Laboratory Medicine, Mayo Medical School; Consultant, Division of Hematology and Internal Medicine and Division of Hematopathology, Mayo Clinic and Mayo Foundation, Rochester, Minnesota

Seymour Grufferman, MD, Professor and Chairman, Department of Family Medicine and Clinical Epidemiology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania

John A. Hansen, MD, Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington

Shelley Heimfeld, PhD, Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington

Dieter Hoelzer, MD, Professor, Department of Internal Medicine; Chief, Department of Hematology, University Hospital, Frankfurt, Germany

James F. Holland, MD, Distinguished Professor, Department of Neoplastic Diseases, Mount Sinai School of Medicine of the City University of New York; Director Emeritus, The Gerald H. Ruttenberg Cancer Center, Mount Sinai Hospital, New York, New York

Jimmie C. Holland, MD, Chairman, Department of Psychiatry and Behavioral Sciences, Wayne E. Chapman Chair of Psychiatric Oncology, Sloan-Kettering Cancer Center, New York, New York

Brian J. P. Huntly, PhD, Department of Haematology, University of Cambridge, Wellcome Trust Centre for Molecular Mechanisms in Disease, Cambridge Institute for Medical Research, Cambridge, England

Elaine S. Jaffe, MD, Chief, Hematopathology Section, Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland

Douglas E. Joshua, MS, BS, DPHIL (OXON), FRACP, FRCPA,

Clinical Professor, Department of Medicine, University of Sydney; Director, Institute of Haematology, Royal Prince Alfred Hospital, Sydney, Australia

Hagop M. Kantarjian, MD, Professor, Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, Texas

Jerry A. Katzmann, PhD, Consultant, Department of Laboratory Medicine and Psychology, Association Professor of Laboratory Medicine Mayo Medical, Mayo Clinic and Mayo Foundation, Rochester, Minnesota

Michael J. Keating, MB, BS, Doctor Kenneth B. McCredie Chair in Clinical Leukemia Research, and Professor, Department of Hematology, University of Texas M.D. Anderson Cancer Center, Houston, Texas

Karen E. King, MD, Fellow, Division of Transfusion Medicine, Department of Pathology, The Johns Hopkins University School of Medicine and the Johns Hopkins Hospital, Baltimore, Maryland

Thomas J. Kipps, MD, PhD, Professor, Department of Medicine, University of California San Diego, La Jolla, California

H. Phillip Koeffler, MD, Professor of Medicine, Division of Hematology/Oncology, Cedars-Sinai Medical Center, UCLA School of Medicine, Los Angeles, California

W. Michael Kuehl, MD, Genetics Department, Medical Branch, National Cancer Institute, Bethesda, Maryland

Joanne Kurtzberg, MD, Professor of Pediatrics; Director, Pedi-atric BMT Program, Duke University Medical Center, Durham, North Carolina

Robert A. Kyle, MD, Consultant, Division of Hematology and Internal Medicine, Mayo Clinic and Mayo Foundation; Professor of Medicine and of Laboratory Medicine, Mayo Medical School, Rochester, Minnesota

Hillard M. Lazarus, MD, FACP, Professor of Medicine, Director, Bone Marrow Transplantation Program, Comprehensive Cancer Center of the University Hospitals of Cleveland, Case Western Reserve University, Cleveland, Ohio

Helen Leather, BPharm, BCPS, Clinical Pharmacy Specialist, Shands Hospital at the University of Florida, Gainesville, Florida

Mark Litzow, MD, Assistant Professor of Medicine, Mayo Clinic, Rochester, Minnesota

Dan L. Longo, MD, Scientific Directory, National Institute on Aging, Baltimore, Maryland

John A. Lust, MD, PhD, Professor, Department of Medicine, Mayo Medical School; Consultant, Division of Hematology and Internal Medicine, Mayo Clinic and Mayo Foundation, Rochester, Minnesota

Tahsine H. Mahfouz, MD, University of Arkansas for Medical Sciences, Little Rock, Arkansas

Paul J. Martin, MD, Fred Hutchinson Cancer Research Center, Seattle, Washington

Susan M. McKenna, MD, Assistant Professor, Division of Pediatrics, Department of Medicine, University of Southern California School of Medicine; Head, Division of Pediatric Oncology, Department of Health Services, Los Angeles County-University of Southern California Medical Center, Los Angeles, California

L. Jeffrey Medeiros, MD, Chief, Lymphoma Section; Professor, Department of Hematopathology, Division of Pathology and Laboratory Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, Texas

Nancy Price Mendenhall, MD, Rodney R. Million Professor of Radiation Oncology, Chairman, Department of Radiation Oncology, University of Florida, Shands Cancer Center, Gainesville, Florida

Maria Messinezy, FRCPath, FRCP, Department of Haematology, Guy's, King's and St. Thomas' School of Medicine, St. Thomas' Hospital, London, England

Carole B. Miller, MD, St. Agnes Healthcare, Baltimore, Maryland

Kenneth B. Miller, MD, Associate Professor of Medicine, Director of Bone Marrow Transplantation, Tufts-New England Medical Center, Boston, Massachusetts

Sandra E. Mitchell, MD, Assistant Professor, Department of Radiation Oncology, University of Florida Health Science Center, Gainesville, Florida

Krzysztof Mrozek, MB, MRCPI, Professor of Medicine, Director, Bone Marrow Transplantation Program, Ohio State University Comprehensive Cancer Center, Columbus, Ohio

Paul M. Ness, MD, Associate Professor, Division of Transfusion Medicine, Department of Pathology, The John Hopkins University School of Medicine; Director, Blood Bank, The Johns Hopkins Hospital, Baltimore, Maryland

Annette J. Neylon, MD, Blood Transfusion Centre, Newcastle Upon Tyne, United Kingdom

Stephen G. O'Brien, PhD, Royal Victoria Infirmary, Newcastle Upon Tyne, United Kingdom

Susan O'Brien, MD, Associate Professor, Department of Leukemia, University of Texas M.D. Anderson Cancer Center, Houston, Texas

Paul V. O'Donnell, MD, PhD, Associate Professor, Fred Hutchinson Cancer Research Center, University of Washington School of Medicine

David G. Oscier, MA, FRCP, FRCPath, Consultant Haematolo-gist, Royal Bournemouth Hospital; Honorary Clinical Senior Lecturer, Southampton University, United Kingdom

Howard Ozer, MD, Eason Chair and Chief, Hematology/Oncol-ogy Section, University of Oklahoma Health Sciences Center; Director, Oklahoma University Cancer Center, Oklahoma City, Oklahoma

Elisabeth Paietta, PhD, Professor of Medicine, Our Lady of Mercy Medical Center, New York Medical College, Valhalla, New York; Director, Clinical Immunology and Stem Cell Laboratory, Our Lady of Mercy Cancer Center, Bronx, New York

Rupesh Parikh, MD, Hematology-Oncology Section, Kaiser Permanente, Fontana, California

Dorothy J. Park, MD, PhD, Assistant Professor, Division of Hematology/Oncology, Cedars-Sinai Medical Center, UCLA School of Medicine, Los Angeles, California

Thomas C. Pearson, MD, Department of Haematology, Guy's, King's, and St. Thomas' School of Medicine, St Thomas' Hospital, London, England

Effie W. Petersdorf, MD, Fred Hutchinson Cancer Center, Seattle, Washington

Bernard J. Poiesz, MD, Professor, Departments of Medicine and Microbiology, Upstate Medical University, State University of New York; Head, Division of Hematology/Oncology, Syracuse, New York

Michael J. Poiesz, BA, Research Assistant, Upstate Medical University, State University of New York; Division of Hematol-ogy/Oncology, Syracuse, New York

Waldemar Pruzanski, MD, Professor of Medicine; Director, Immunology Diagnostic and Research Center; Director, Clinical Immunology and Allergy; Director, Inflammation Research Group, University of Toronto; Head, Division of Immunology, The Wellesley Hospital, Toronto, Ontario, Canada

S. Vincent Rajkumar, MD, Associate Professor of Medicine, Mayo Medical School, Mayo Clinic, Rochester, Minnesota

John T. Reilly, MD, Department of Haematology, Royal Hal-lamshire Hospital, Sheffield, United Kingdom

Julie A Ross, PhD, Division of Pediatric Epidemiology and Clinical Research, University of Minnesota Cancer Center, Minneapolis, Minnesota

Andrew J. Roth, MD, Assistant Professor, Department of Psychiatry, Cornell University Medical College; Assistant Attending Psychiatrist, Psychiatry Service, Memorial Sloan-Kettering Cancer Center, New York, New York

Matt Rowley, PhD, Department of Genetics, Cell Biology, and Development, The University of Minnesota, Minneapolis, Minnesota

Armando Santoro, MD, Director, Department of Medical Oncology and Hematology, Istituto Clinico Humanitas, Roz-zano (Milano), Italy

Alan Saven, MD, Division of Hematology/Oncology, Scripps Clinic, Ida M. and Cecil H. Green Cancer Center Division, The Scripps Cancer Center, La Jolla, California

Charles A. Schiffer, MD, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan

Arthur T. Skarin, MD, Associate Professor, Department of Medicine, Harvard Medical School; Director, Hematology Laboratory, Division of Medical Oncology, Department of Medicine, Dana-Farber Cancer Institute, Boston, Massachusetts

Richard M. Stone, MD, Assistant Professor, Department of Medicine, Harvard Medical School; Associate Physician, Division of Medical Oncology, Department of Medicine, Dana-Farber Cancer Institute, Boston, Massachusetts

Martin S. Tallman, MD, Associate Professor of Medicine, Director, Leukemia Program, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois

Moshe Talpaz, MD, Professor and Chairman, Department of Bioimmunotherapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas

Nizar Tannir, MD, FACP, Department of Leukemia The University of Texas M.D. Anderson Cancer Center, Houston, Texas

Nukhet N. Tuzuner, MD, Professor, Department of Pathology, Istanbul University Carrahpasa Medical Faculty, Istanbul, Turkey

Brian Van Ness, PhD, Professor and Head, Department of Genetics, Cell Biology, and Development, University of Minnesota, Minneapolis, Minnesota

Julie M. Vose, MD, Associate Professor, Section of Oncology and Hematology, Department of Internal Medicine, University of Nebraska College of Medicine, Omaha, Nebraska

Dietlind Wahner-Roedler, MD, Consultant, Division of Area General Internal Medicine, Mayo Clinic and Mayo Foundation; Assistant Professor of Medicine, Mayo Medical School, Rochester, Minnesota

Howard J. Weinstein, MD, Associate Professor, Division of Hematology-Oncology, Department of Pediatrics, Harvard Medical School; Dana-Farber Cancer Institute, Children's Hospital, Boston, Massachusetts

Sheila Weitzman, MD, ChB, FRCP, FCP(SA), The Hospital for Sick Children, Toronto, Ontario, Canada

Peter H. Wiernik, MD, Professor of Medicine and Radiation Oncology, New York Medical College; Director, Comprehensive Cancer Center, Our Lady of Mercy Medical Center, New York Medical College, Bronx, New York

John R. Wingard, MD, Professor of Medicine, University of Florida School of Medicine; Director, Bone Marrow Transplant Program, University of Florida College of Medicine, Gainesville, Florida

10 Ways To Fight Off Cancer

10 Ways To Fight Off Cancer

Learning About 10 Ways Fight Off Cancer Can Have Amazing Benefits For Your Life The Best Tips On How To Keep This Killer At Bay Discovering that you or a loved one has cancer can be utterly terrifying. All the same, once you comprehend the causes of cancer and learn how to reverse those causes, you or your loved one may have more than a fighting chance of beating out cancer.

Get My Free Ebook


Post a comment